Skip to content

TRANS AMERICAN AQUACULTURE, INC.: 10-Q filed 2026-01-14

What TRANS AMERICAN AQUACULTURE, INC. reported in its quarterly report filed 2026-01-14 (fiscal Q3 2025): 34 published measures, 105 facts as tagged in accession 0001683168-26-000292.

This filing

Form
10-Q (quarterly report)
Filed
2026-01-14
Fiscal period
fiscal Q3 2025
Accession
0001683168-26-000292 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TRANS AMERICAN AQUACULTURE, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-09-301,106,686USD
At 2024-12-31948,015USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-09-30-3,758,603USD
At 2025-06-30-3,719,207USD
At 2025-03-31-3,302,692USD
At 2024-12-31-3,221,985USD
At 2024-09-30-1,645,849USD
At 2024-06-30-1,047,609USD
At 2024-03-31-717,298USD
At 2023-12-31-479,277USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-09-30509USD
At 2024-12-310USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-171,642USD92
2025-01-01 to 2025-09-30-489,387USD273
2025-04-01 to 2025-06-30-204,038USD91
2025-01-01 to 2025-03-31-113,707USD90
2024-07-01 to 2024-09-30-575,325USD92
2024-01-01 to 2024-09-30-1,143,656USD274
2024-04-01 to 2024-06-30-330,311USD91
2024-01-01 to 2024-03-31-238,021USD91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-09-30-771,113USD273
2024-01-01 to 2024-09-30-442,196USD274

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2025-07-01 to 2025-09-300USD92
2025-01-01 to 2025-09-300USD273
2024-07-01 to 2024-09-300USD92
2024-01-01 to 2024-09-30315,145USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-09-30743,696USD273
2024-01-01 to 2024-09-30428,102USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-01-01 to 2025-09-3021,232USD273
2024-01-01 to 2024-09-307,494USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-09-30-6,164,954USD
At 2024-12-31-5,675,567USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-07-01 to 2025-09-301,805,926,955shares92
2025-01-01 to 2025-09-301,805,926,955shares273
2024-07-01 to 2024-09-301,471,954,105shares92
2024-01-01 to 2024-09-301,464,204,910shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-0.000095USD/shares92
2025-01-01 to 2025-09-30-0.000271USD/shares273

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-0.000095USD/shares92
2025-01-01 to 2025-09-30-0.000271USD/shares273
2024-07-01 to 2024-09-30-0.000328USD/shares92
2024-01-01 to 2024-09-30-0.000378USD/shares274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2025-07-01 to 2025-09-300USD92
2025-01-01 to 2025-09-300USD273
2024-07-01 to 2024-09-300USD92
2024-01-01 to 2024-09-300USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-09-30766,564USD
At 2024-12-31690,705USD

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-09-30340,123USD
At 2024-12-31257,310USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-09-304,719,609USD
At 2024-12-313,608,912USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2025-09-30751,883USD
At 2024-12-31530,776USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2025-09-30338,898USD
At 2024-12-31230,830USD
At 2024-09-30222,234USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-300USD92
2025-01-01 to 2025-09-300USD273
2024-07-01 to 2024-09-30-196,552USD92
2024-01-01 to 2024-09-30-104,706USD274

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2025-07-01 to 2025-09-300USD92
2025-01-01 to 2025-09-300USD273
2024-07-01 to 2024-09-30196,552USD92
2024-01-01 to 2024-09-30419,851USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-09-301,805,926,955shares
At 2024-12-311,805,926,955shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-09-30509USD
At 2024-12-316,694USD
At 2024-09-300USD
At 2023-12-316,600USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2025-09-30471,429USD
At 2024-12-31547,287USD
At 2024-09-30547,287USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-171,642USD92
2025-01-01 to 2025-09-30-489,387USD273
2024-07-01 to 2024-09-30-575,325USD92
2024-01-01 to 2024-09-30-1,143,656USD274
2020-01-01 to 2020-12-31155,200USD366

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2025-07-01 to 2025-09-3083,396USD92
2025-01-01 to 2025-09-30266,357USD273
2024-07-01 to 2024-09-30213,250USD92
2024-01-01 to 2024-09-30534,633USD274

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2025-01-01 to 2025-09-304,865USD273
2024-01-01 to 2024-09-3052,291USD274

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2025-07-01 to 2025-09-3088,246USD92
2025-01-01 to 2025-09-30215,528USD273
2024-07-01 to 2024-09-30175,836USD92
2024-01-01 to 2024-09-30449,356USD274

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-07-01 to 2025-09-30-88,246USD92
2025-01-01 to 2025-09-30-223,030USD273
2024-07-01 to 2024-09-30-165,523USD92
2024-01-01 to 2024-09-30-504,317USD274

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

PeriodValueUnitDays
2025-01-01 to 2025-09-300USD273
2024-01-01 to 2024-09-300USD274

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2025-01-01 to 2025-09-300USD273
2024-01-01 to 2024-09-300USD274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2025-01-01 to 2025-09-300USD273
2024-01-01 to 2024-09-3084,496USD274

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2025-01-01 to 2025-09-300USD273
2024-01-01 to 2024-09-300USD274

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2024-05-28 to 2024-05-2912,715USD2
2024-02-26 to 2024-02-272,106USD2

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-09-30110,546USD273
2024-01-01 to 2024-09-30-25,591USD274

Inspect the source

Entity
TRANS AMERICAN AQUACULTURE, INC. / CIK 0001990446
Captured
2026-09-21T17:37:50.085Z
SEC response SHA-256
de39df3cfb039e59fe304972d0b52a5e4f8d05444d2f61fffcc11024b8c8fdc5

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001990446.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))